DRUG NAME: Crizotinib
Crizotinib BC Cancer Agency Cancer Drug Manual© Page 2 of 6 Crizotinib Developed: 1 April 2014 Revised: 1 September 2014. Caution: • vision disorders. have been reported; ability to drive or operate machinery may be compromised.
Download DRUG NAME: Crizotinib
Information
Domain:
Source:
Link to this page:
Documents from same domain
Oncology Nutrition High Protein High Energy …
www.bccancer.bc.caHigh Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
Safe Handling of Hazardous Drugs - BC Cancer
www.bccancer.bc.caA.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
Symptom Management Guidelines: ORAL …
www.bccancer.bc.caSymptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …
Guidelines for Management of CID - BC Cancer
www.bccancer.bc.caDisclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide
British Columbia Cancer Agency POLICY
www.bccancer.bc.caBritish Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997
Symptom Management Guidelines: FEVER AND …
www.bccancer.bc.caSymptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h
Symptom Management Guidelines: XEROSTOMIA
www.bccancer.bc.caSymptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be
Linking the BC Psychosocial Community Oncology …
www.bccancer.bc.caCarolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC
Related documents
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - ALOXI
www.aloxi.comHIGHLIGHTS OF PRESCRIBING INFORMATION . These highlights do not include all the information needed to use ALOXI safely and effectively. See full prescribing information for ALOXI
DRUG NAME: Oxaliplatin - BC Cancer
www.bccancer.bc.ca• QT prolongation and torsades de pointes are reported; use caution in patients with history of QT prolongation or cardiac disease and those receiving concurrent therapy with other QT prolonging
DRUG INDUCED QT PROLONGATION - GGC Prescribing
www.ggcprescribing.org.ukIssue 21, December 2012 Produced by NHS Greater Glasgow and Clyde Medicines Information Service . DRUG INDUCED QT PROLONGATION Prolongation of the QT interval can lead to a
DATA SHEET 1 LARGACTIL 10 MG, 25 MG, 100 MG FILM …
www.medsafe.govt.nzNew Zealand Data Sheet 13-Nov-2018 Largactil - chlorpromazine HCl Property of the Sanofi group - strictly confidential largactil-ccdsv3-dsv10-28nov18 Page 5
1 PRODUCT NAME - Medsafe
www.medsafe.govt.nzNew Zealand Data Sheet September 2018 Stemetil Stemetil-ccsiv4-dsv11-21sep18 Page 1 DATA SHEET STEMETIL® 1 PRODUCT NAME Non-proprietary Name
The Cost-Effectiveness of Thorough QT/QTc (TQT) studies
www.safetypharmacology.orgRisk of a drug-induced sudden cardiac death in users of the prototype antipsychotic Proarrhythmic (>500ms) QTc prolongation: 1% of users Risk of Torsade de pointes in patients with